References
- Lee AWM, Perez CA, Law SCK, Chua DTT, Wei WI, Chong V. 2008. Nasopharynx. In: Halperin EC, Perez CA, Brady LW, editors. Perez and Brady's principles and practice of radiation oncology, 5th edn. Philadelphia: Lippincott Williams & Wilkins. p 821–58.
- Eser SOS, Yakut C, Nazlı T. 2007. Cancer incidence in Izmir, Turkey, 1998–2002. In: Curado MP, Edwards B, Shin HR, Storm H, Ferlay M, Heanue M, , editors. Cancer incidence in five continents, Vol IX. IARC Scientific Publications, no. 160. Lyon: IARC.
- Lee N, Xia P, Quivey JM, Sultanem K, Poon I, Akazawa C, Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 2002;53:12–22.
- Baujat B, Audry H, Bourhis J, Chan AT, Onat H, Chua DT, Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys 2006;64:47–56.
- Huncharek M, Kupelnick B. Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma: results of a meta-analysis of 1,528 patients from six randomized trials. Am J Clin Oncol 2002;25:219–23.
- Chua DT, Sham JS, Choy D, Lorvidhaya V, Sumitsawan Y, Thongprasert S, Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group. Cancer 1998;83:2270–83.
- Ozyar E, Gurkaynak M, Yildiz F, Atahan IL. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival. Radiother Oncol 2004;72:71–7.
- Sham JS, Choy D. Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients. Br J Radiol 1990;63:51–8.
- Akman F, Bayman E, Ataman OU, Ecevit C, Ada E, Sarioglu S, Results of “Dokuz Eylul Head and Neck Cancers Group (DEHNCG) -Treatment Protocol” in the nasopharynx carcinoma and to examine of prognostic factors. Turkish Journal of Oncology 2005;20:3–12.
- Sidler D, Thum P, Winterhalder R, Huber G, Haerle SK. Undifferentiated carcinoma of nasopharyngeal type (UCNT): a Swiss single-institutional experience during 1990–2005. Swiss Med Wkly 2010;140:273–9.
- Chua DT, Sham JS, Choy DT. Prognostic impact of hemoglobin levels on treatment outcome in patients with nasopharyngeal carcinoma treated with sequential chemoradiotherapy or radiotherapy alone. Cancer 2004;101:307–16.
- Gao J, Hu JY, Xia YF, Yi W, Tao YL, Li G. Continuous fall in hemoglobin level is a poor prognostic factor in patients with nasopharyngeal carcinoma treated with radiotherapy. Chin J Cancer 2010;29:561–6.
- Feng AC, Wu MC, Tsai SY, Chan KY, Cheng SH, Wang A, Prevertebral muscle involvement in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2006;65:1026–35.
- Lee CC, Chu ST, Ho HC, Hung SK. Primary tumor volume calculation as a predictive factor of prognosis in nasopharyngeal carcinoma. Acta Otolaryngol 2008;128:93–7.
- Liao XB, Mao YP, Liu LZ, Tang LL, Sun Y, Wang Y, How does magnetic resonance imaging influence staging according to AJCC staging system for nasopharyngeal carcinoma compared with computed tomography? Int J Radiat Oncol Biol Phys 2008;72:1368–77.
- Kim YS, Kim BS, Jung SL, Lee YS, Kim MS, Sun DI, Radiation therapy combined with (or without) cisplatin-based chemotherapy for patients with nasopharyngeal cancer: 15-years experience of a single institution in Korea. Cancer Res Treat 2008;40:155–63.
- Farias TP, Dias FL, Lima RA, Kligerman J, de Sa GM, Barbosa MM, Prognostic factors and outcome for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2003;129:794–9.
- Ponzanelli A, Vigo V, Marcenaro M, Bacigalupo A, Gatteschi B, Ravetti JL, Induction chemotherapy followed by alternating chemo-radiotherapy in non-endemic undifferentiated carcinoma of the nasopharynx: optimal compliance and promising 4-year results. Oral Oncol 2008;44:767–74.
- Yee D, Hanson J, Lau H, Siever J, Gluck S. Treatment of nasopharyngeal carcinoma in the modern era: analysis of outcomes and toxicity from a single center in a nonendemic area. Cancer J 2006;12:147–54.